Clinical Trials Logo
  1. Home
  2. Drug Hypersensitivity
  3. NCT05269082

A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

Drug Hypersensitivity Clinical Trial

Official title:
In Vitro Assessment of Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood From Patients at Increased Risk of Developing Hypersensitivity Reactions

Clinical Trial Summary

The aim of this study is to find out whether TAK-880 creates hypersensitivity reactions compared to Gammagard S/D by testing blood taken from participants who have a higher risk of becoming hypersensitive to immunoglobulin products. This study is about collecting data available in the participant's medical record. No study medicines will be provided to participants in this study. Each participant will fill out a study questionnaire during a routine doctor visit. Blood will be taken from participants who have a higher risk of developing hypersensitivity reactions to immunoglobulin products.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05269082
Study type Observational
Source Takeda
Contact
Status Completed
Phase
Start date April 5, 2022
Completion date September 19, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT02839551 - Optimal Doses for Drug Provocation Tests to Beta-lactams N/A
Completed NCT00198419 - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Phase 1
Completed NCT02839811 - Medical Device for Drug Allergy Diagnosis N/A
Completed NCT02983630 - Allergy Testing of Patients Labeled as Penicillin Allergic N/A
Completed NCT00198458 - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Phase 1
Recruiting NCT04330118 - Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Completed NCT04421638 - Cephalosporin Hypersensitivity
Recruiting NCT02031120 - Management of Drug Hypersensitivity in Children N/A
Completed NCT01276314 - Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions N/A
Terminated NCT00505648 - Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Phase 3
Completed NCT03158831 - Drug Challenges Without Prior Skin Testing Phase 1
Completed NCT03076749 - Predictive Models for Betalactam Allergy N/A
Active, not recruiting NCT06428162 - An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community
Terminated NCT02844712 - Negative Predictive Value of Drug Provocation Tests to Beta-lactams N/A
Completed NCT03743220 - Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)
Completed NCT03771118 - Drug Provocation Test (DPT) to Paracetamol
Not yet recruiting NCT06406114 - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Phase 2
Completed NCT04827602 - Drug Allergy Labels After Drug Allergy Investigation